Cynata Therapeutics Ratios and Metrics

Market cap in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 30, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Capitalization	72	34	53	22	52	72
Market Cap Growth	52.63%	-36.04%	136.00%	-56.47%	-28.71%	1.27%
Enterprise Value	70	23	42	6	25	47
Last Close Price	0.30	0.15	0.29	0.13	0.36	0.51
PS Ratio	42.92	17.98	22.88	13.57	6.64	46.80
PB Ratio	21.38	5.67	7.34	1.34	2.15	2.55
P/TBV Ratio	21.38	5.67	7.34	1.34	2.15	2.55
EV/Sales Ratio	41.39	12.41	18.06	3.65	3.19	30.68
Net Debt / Equity Ratio	-0.76	-0.84	-0.86	-0.97	-0.99	-0.94
Net Debt / EBITDA Ratio	0.31	0.54	0.62	1.11	4.11	3.68
Asset Turnover	0.19	0.24	0.17	0.07	0.28	0.07
Quick Ratio	2.36	4.24	5.39	7.30	9.23	16.71
Current Ratio	2.49	4.40	5.58	7.46	9.33	17.03
Return on Equity (ROE)	-112.99%	-142.29%	-81.37%	-70.17%	-20.81%	-34.05%
Return on Assets (ROA)	-62.05%	-77.08%	-46.70%	-40.86%	-13.42%	-19.85%
Return on Capital Employed (ROCE)	-254.50%	-160.70%	-141.70%	-89.00%	-25.30%	-26.60%
Earnings Yield	-11.60%	-27.71%	-18.39%	-63.59%	-10.56%	-10.63%
Buyback Yield / Dilution	-26.09%	-14.09%	-23.80%	-1.27%	-9.85%	-24.80%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.